openPR Logo
Press release

Family Skincare Brand 'iBodle' Marks U.S. Market Entry with Successful Launch on Amazon

02-11-2025 07:26 PM CET | Politics, Law & Society

Press release from: ABNewswire

Family Skincare Brand 'iBodle' Marks U.S. Market Entry with

Image: https://www.abnewswire.com/upload/2025/02/d624824becffa9bf27dbd5ebe11b3848.jpg

The family skincare brand iBodle , developed by NAAAMYUU FNC, has officially stepped into the U.S. market with a successful launch on Amazon US this past November. The brand's flagship product, the CCP Cream, achieved near sell-out success during the Black Friday event, demonstrating strong market potential and positive reception.

iBodle is a brand born from the philosophy of "a mother's love and determination". The founder and CEO of NAAAMYUU FNC, was inspired to create the brand as a mother of four children who struggled to find safe and effective skincare solutions for her kids' sensitive skin. Witnessing her children lose sleep due to itchy skin, she tried popular moisturizers but was dissatisfied with their lack of efficacy or concerning ingredients. These personal experiences drove her to develop skincare products that meet the highest safety and quality standards, leading to the establishment of iBodle . Since its inception, the brand has gained recognition through word-of-mouth recommendations, thanks to its heartfelt approach and uncompromising standards.

"I take pride in iBodle's growth, which has been built on trust and recommendations from our customers," said CEO, Nam Yu-suk. "Our launch on Amazon US is a significant first step in sharing the value of iBodle with a global audience. We remain committed to prioritizing customer trust as we expand further." She also expressed gratitude to international customers who have consistently supported the brand through its domestic e-commerce platform's EMS shipping service. Looking ahead, Nam revealed her ambition to introduce other NAAAMYUU FNC brands, such as NAAAMYUUU and Very Hour , to global markets by 2025.

Image: https://www.abnewswire.com/upload/2025/02/ed19b8741c43efd6ada9d403dda9fc37.jpg

In 2024, NAAAMYUU FNC laid the groundwork for its international expansion through partnerships with Hyundai Duty-Free and Lotte Duty-Free stores. Building on the momentum from its Amazon launch, iBodle is gearing up with a variety of marketing and distribution strategies to reach a broader global audience. Known for its unique ingredients and exceptional product performance, the brand is poised to become a trusted name among international consumers, just as it has in its home market.

Staying true to its core value of creating "the safest and most effective skincare for families," iBodle continues to invest in research and development. With a mission to enrich lives with innovative products, the brand aims to become a source of satisfaction and happiness for its customers around the world.

Media Contact
Company Name: NAAAMYUUU FNC
Contact Person: Dogyeong Lee
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=family-skincare-brand-ibodle-marks-us-market-entry-with-successful-launch-on-amazon]
Country: South Korea
Website: https://www.amazon.com/stores/iBodleFeelourAmazingCCPEffect/page/55B47CFA-B0EF-41F4-A526-BCB5EAE88B5F?ref_=ast_bln

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Family Skincare Brand 'iBodle' Marks U.S. Market Entry with Successful Launch on Amazon here

News-ID: 3863379 • Views:

More Releases from ABNewswire

Cabinets 4 Less Tempe, AZ Opens New Showroom Offering Affordable Cabinet Solutions
Cabinets 4 Less Tempe, AZ Opens New Showroom Offering Affordable Cabinet Solutio …
Cabinets 4 Less Tempe, AZ has opened a new showroom at 1840 E Warner Rd Suite 116, offering affordable and stylish cabinetry for kitchens, bathrooms, and home projects. The cabinet store provides homeowners, contractors, and designers with a wide selection of styles and finishes, quick order fulfillment, and personalized service to make high-quality cabinets accessible across the Tempe community. TEMPE, AZ - September 30, 2025 - Cabinets 4 Less Tempe, AZ
Non Muscle Invasive Bladder Cancer Pipeline 2025: Pioneering Clinical Developments by 20+ Global Leaders - DelveInsight | Featuring Johnson & Johnson Innovative Medicine, Asieris Pharmaceuticals
Non Muscle Invasive Bladder Cancer Pipeline 2025: Pioneering Clinical Developmen …
Non Muscle Invasive Bladder Cancer companies are Pfizer, Theralase Technologies, Protara Therapeutics, Zhuhai Beihai Biotech Co., Ltd, Vaxiion Therapeutics, Aura Biosciences, Ractigen Therapeutics, Tyra Biosciences, Hoffmann-La Roche, SURGE Therapeutics, CG Oncology, Inc., Trigone Pharma Ltd., Merck Sharp & Dohme LLC, and others. With Non Muscle Invasive Bladder Cancer (NMIBC) increasingly impacting populations worldwide and contributing to comorbidities such as diabetes, cardiovascular disease, and certain cancers, the need for safer and more
Bardet-Biedl Syndrome Pipeline 2025: Pioneering Clinical Developments by 8+ Global Leaders - DelveInsight | Featuring Rhythm Pharmaceuticals
Bardet-Biedl Syndrome Pipeline 2025: Pioneering Clinical Developments by 8+ Glob …
DelveInsight's, "Bardet-Biedl Syndrome - Pipeline Insight, 2025," report provides comprehensive insights about 1+ companies and 1+ pipeline drugs in Bardet-Biedl Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With Bardet-Biedl Syndrome (BBS) increasingly impacting populations worldwide and contributing
Brain Metastases Pipeline 2025: Pioneering Clinical Advancements by 40+ Global Leaders - DelveInsight | Featuring HUYA Bioscience, Kazia Therapeutics, BioMimetix, EpicentRx, Inc., Angiochem, Medolutio
Brain Metastases Pipeline 2025: Pioneering Clinical Advancements by 40+ Global L …
Brain Metastases companies are Betta Pharmaceuticals Co., Ltd., Merck Sharp & Dohme LLC, Bristol-Myers Squibb, 2-BBB Medicines, DEKK-TEC, Inc., Nascent Biotech, Quadriga Biosciences, Inc., Jubilant Therapeutics, Denali Therapeutics Inc, NUVATION BIO, Novocure GmbH, Affinia Therapeutics, Specialised Therapeutics, Precirix, Ashvattha Therapeutics, Cereius, Allarity Therapeutics, TYK Medicine, Surgimab, ORIC Pharmaceuticals, SonALAsense, Nerviano Medical Sciences, Lin Bioscience, and others. With brain metastases increasingly prevalent worldwide and contributing to comorbid conditions such as diabetes, cardiovascular

All 5 Releases